Literature DB >> 6187010

Modifiers of free radicals inhibit in vitro the oncogenic actions of x-rays, bleomycin, and the tumor promoter 12-O-tetradecanoylphorbol 13-acetate.

C Borek, W Troll.   

Abstract

Using short-term cultures of hamster embryo cells, we have examined the effects of the free-radical scavenger superoxide dismutase (superoxide:superoxide oxidoreductase, EC 1.15.1.1) and the enzyme catalase (hydrogen-peroxide:hydrogenperoxide oxidoreductase, EC 1.11.1.6) on x-ray- and bleomycin-induced transformation and on the enhancement of radiogenic transformation by the tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA). We find that superoxide dismutase inhibits (i) transformation induced by x-ray and bleomycin and (ii) promotional action of TPA in vitro. The results suggest that the oncogenic action of x-rays and bleomycin and the enhancement of oncogenic transformation by TPA are mediated in part by free radicals. The findings also suggest that superoxide dismutase can serve as an inhibitor of oncogenesis and that its actions, as seen in this in vitro system, are most predominantly on inhibiting late events in the progression of cellular transformation--those associated with promotion.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6187010      PMCID: PMC393585          DOI: 10.1073/pnas.80.5.1304

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  A possible naturally occurring tumor promoter, teleocidin B from Streptomyces.

Authors:  H Fujiki; M Mori; M Nakayasu; M Terada; T Sugimura
Journal:  Biochem Biophys Res Commun       Date:  1979-10-12       Impact factor: 3.575

Review 2.  Radiation protection by superoxide dismutase.

Authors:  A Petkau
Journal:  Photochem Photobiol       Date:  1978 Oct-Nov       Impact factor: 3.421

3.  Conditions for inhibiting and enhancing effects of the protease inhibitor antipain on x-ray-induced neoplastic transformation in hamster and mouse cells.

Authors:  C Borek; R Miller; C Pain; W Troll
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

4.  Regression of aflatoxin B1-induced hepatocellular carcinomas by reduced glutathione.

Authors:  A M Novi
Journal:  Science       Date:  1981-05-01       Impact factor: 47.728

5.  Protective role of the glutathione redox cycle against adriamycin-mediated toxicity in isolated hepatocytes.

Authors:  J R Babson; N S Abell; D J Reed
Journal:  Biochem Pharmacol       Date:  1981-08-15       Impact factor: 5.858

6.  Drug-induced lipid peroxidation in mice--I. Modulation by monooxygenase activity, glutathione and selenium status.

Authors:  A Wendel; S Feuerstein
Journal:  Biochem Pharmacol       Date:  1981-09-15       Impact factor: 5.858

7.  Nuclear distribution of aflatoxin B1 and its interaction with histones in rat liver in vivo.

Authors:  J D Groopman; W F Busby; G N Wogan
Journal:  Cancer Res       Date:  1980-12       Impact factor: 12.701

8.  Skin tumor-promoting activity of benzoyl peroxide, a widely used free radical-generating compound.

Authors:  T J Slaga; A J Klein-Szanto; L L Triplett; L P Yotti; K E Trosko
Journal:  Science       Date:  1981-08-28       Impact factor: 47.728

Review 9.  Aspects of free radical reactions in biological systems: aging.

Authors:  B E Leibovitz; B V Siegel
Journal:  J Gerontol       Date:  1980-01

10.  Stimulation of human polymorphonuclear leukocyte superoxide anion radical production by tumor promoters.

Authors:  B D Goldstein; G Witz; M Amoruso; D S Stone; W Troll
Journal:  Cancer Lett       Date:  1981-01       Impact factor: 8.679

View more
  19 in total

Review 1.  Reactive oxygen intermediates involved in cellular regulation.

Authors:  B Meier
Journal:  Protoplasma       Date:  2001       Impact factor: 3.356

2.  p53-independent inhibition of proliferation and p21(WAF1/Cip1)-modulated induction of cell death by the antioxidants N-acetylcysteine and vitamin E.

Authors:  J L Nargi; R R Ratan; D E Griffin
Journal:  Neoplasia       Date:  1999-12       Impact factor: 5.715

3.  Reduced superoxide dismutase activity in UVB-induced hyperproliferative pig epidermis.

Authors:  Y Hashimoto; N Ohkuma; H Iizuka
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

4.  Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome.

Authors:  C J Epstein; K B Avraham; M Lovett; S Smith; O Elroy-Stein; G Rotman; C Bry; Y Groner
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

Review 5.  Antioxidants reduce consequences of radiation exposure.

Authors:  Paul Okunieff; Steven Swarts; Peter Keng; Weimin Sun; Wei Wang; Jung Kim; Shanmin Yang; Hengshan Zhang; Chaomei Liu; Jacqueline P Williams; Amy K Huser; Lurong Zhang
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

6.  Cell killing and DNA damage by hydrogen peroxide are mediated by intracellular iron.

Authors:  A C Mello Filho; M E Hoffmann; R Meneghini
Journal:  Biochem J       Date:  1984-02-15       Impact factor: 3.857

7.  Heparin-induced release of extracellular superoxide dismutase to human blood plasma.

Authors:  K Karlsson; S L Marklund
Journal:  Biochem J       Date:  1987-02-15       Impact factor: 3.857

8.  Production of thymine glycols in DNA by radiation and chemical carcinogens as detected by a monoclonal antibody.

Authors:  S A Leadon
Journal:  Br J Cancer Suppl       Date:  1987-06

9.  Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells.

Authors:  S L Church; J W Grant; L A Ridnour; L W Oberley; P E Swanson; P S Meltzer; J M Trent
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

10.  Toxicodynamics of tumour promoters of mouse skin. II. Binding to protein kinase C of some new diterpene esters and induction of luminol-enhanced chemoluminescence in mouse peritoneal neutrophils.

Authors:  M Hergenhahn; U Kloz; M Fellhauer; G L Tremp; E Hecker
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.